Insider · CIK 0001289946

Broom Colin MD

CIK 0001289946 Name as filed on the most recent filing

Filed as Broom Colin MD (18)

41 transaction lines · from 18 filings · filed 2008-09-16 to 2022-08-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

41 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-08-02 S, Open-market sale Nabriva Therapeutics plcNBRV 1,015, disposed Open Form 4 filing 0001104659-22-086280
2021-08-02 S, Open-market sale Nabriva Therapeutics plcNBRV 637, disposed Open Form 4 filing 0001104659-21-100289
2020-08-20 S, Open-market sale Nabriva Therapeutics plcNBRV 7,165, disposed Open Form 4 filing 0001104659-20-097717
2019-08-30 P, Open-market purchase Nabriva Therapeutics plcNBRV 20,668, acquired Open Form 4 filing 0001104659-19-048436
2019-08-21 S, Open-market sale Nabriva Therapeutics plcNBRV 21,066, disposed Open Form 4 filing 0001104659-19-047351
2018-06-22 P, Open-market purchase Nabriva Therapeutics plcNBRV 18,600, acquired Open Form 4 filing 0001104659-18-041953
2018-05-23 P, Open-market purchase Nabriva Therapeutics plcNBRV 46,000, acquired Open Form 4 filing 0001104659-18-035535
2017-09-22 P, Open-market purchase Nabriva Therapeutics plcNBRV 21,610, acquired Open Form 4 filing 0001104659-17-058896
2013-02-07 S, Open-market sale NPS Pharmaceuticals IncNPSP 53,314, disposed Open Form 4 filing 0001474064-13-000022
2012-12-24 S, Open-market sale Viropharma IncVPHM 394,301, disposed Open Form 4 filing 0001127602-12-035162
2012-12-24 S, Open-market sale Viropharma IncVPHM 394,301, disposed Open Form 4 filing 0001127602-12-035085
2012-12-10 S, Open-market sale Viropharma IncVPHM 3 lines 1,805,016, disposed Open Form 4 filing 0001127602-12-033702
2011-12-14 S, Open-market sale Viropharma IncVPHM 2 lines 1,266,750, disposed Open Form 4 filing 0001127602-11-032359
2011-12-13 S, Open-market sale Viropharma IncVPHM 524,755, disposed Open Form 4 filing 0001127602-11-032247
2011-12-12 S, Open-market sale Viropharma IncVPHM 415,317, disposed Open Form 4 filing 0001127602-11-032247
2011-11-07 S, Open-market sale Viropharma IncVPHM 2 lines 420,002, disposed Open Form 4 filing 0001127602-11-028951
2011-11-01 S, Open-market sale Viropharma IncVPHM 483,641, disposed Open Form 4 filing 0001127602-11-028417
2011-10-31 S, Open-market sale Viropharma IncVPHM 418,555, disposed Open Form 4 filing 0001127602-11-028417
2010-09-13 S, Open-market sale Viropharma IncVPHM 7 lines 67,207, disposed Open Form 4 filing 0001127602-10-022961
2010-09-10 S, Open-market sale Viropharma IncVPHM 5 lines 104,692, disposed Open Form 4 filing 0001127602-10-022961
2010-09-09 S, Open-market sale Viropharma IncVPHM 5 lines 225,867, disposed Open Form 4 filing 0001127602-10-022961
2008-09-12 S, Open-market sale Viropharma IncVPHM 2 lines 361,263, disposed Open Form 4 filing 0001181431-08-053458

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 37
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Broom Colin MD, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001289946

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.